|
30 Nov 2010 |
miRagen Therapeutics and t2cure Sign Licensing Agreement for microRNA Target Implicated in Vascular Disease
|
|
30 Nov 2010 |
Advanced Cell Technology Files IND with FDA for First Clinical Trial Using Embryonic Stem Cells to Treat Dry AMD
|
|
29 Nov 2010 |
Oncolytics Biotech Inc. Announces Publication of Phase I Clinical Trial Results Examining Combination of REOLYSIN and Docetaxel in Clinical Cancer Research
|
|
29 Nov 2010 |
Hemispherx Biopharma Files With the FDA a Request to Maintain as Active Hemispherx NDA for Ampligen(R) to Treat Chronic Fatigue Syndrome (CFS)
|
|
23 Nov 2010 |
BioAlliance Pharma Presents Preclinical and Phase I Clinical Results with Its AMEP Biotherapy for Metastatic Melanoma
|
|
22 Nov 2010 |
Hemispherx Publishes New Data on Ampligen(R)'s Activity in Chronic Fatigue Syndrome (CFS)
|
|
22 Nov 2010 |
Advanced Cell Technology Receives FDA Clearance For the First Clinical Trial Using Embryonic Stem Cells to Treat Macular Degeneration
|
|
19 Nov 2010 |
Baxter Announces Acquisition of All Hemophilia-Related Assets of Archemix and an Exclusive License of Its Anti-TFPI Aptamer Technology
|
|
18 Nov 2010 |
Aastrom Presents Positive Second Interim Analysis of Phase 2b RESTORE-CLI Clinical Trial
|
